Determination of dose enhancement caused by gold-nanoparticles irradiated with proton, X-rays (kV and MV) and electron beams, using alanine/EPR dosimeters

• Dose enhancement by 5 nm AuNPs (3% within alanine) determined for various beam types
• Alanine/3% AuNPs composites show potential as low dose radiotherapy dosimeters (kV)
• Alanine doped with AuNPs gave ∼60% dose enhancement for kV and ∼10% for MV X-rays
• Alanine doped with AuNPs gave ≤5% dose enhancement for electron and proton beams
• Good agreement with results for dose enhancement in cell and simulation studies

The main aims of this research was to employ alanine doped with gold-nanoparticles “AuNPs” to determine the levels of dose enhancement caused by these particles when irradiated with proton beams, low and high energy X-rays and electrons.dl-alanine was impregnated with 5 nm gold-nanoparticles (3% by weight) and added as a uniform layer within a wax pellet of dimensions 10 × 5 × 5 mm. Control pellets, containing dl-Alanine were also produced, and placed within a phantom, and exposed to various types of radiations: low energy (kV ranges) X-rays were obtained from a superficial machine, high energy (MV) X-rays and electrons derived from a linear accelerator, and protons were produced by the Hyogo Ion Beam Centre in Japan. Nominal doses received ranged from 2 to 20 Gy (within clinical range). The Electron Paramagnetic Resonance (EPR) spectra of the irradiated samples were recorded on a BRUKER Elexsys 9.5 MHz.The dose enhancement caused by gold nanoparticles for 80 kV x-rays was found to be more than 60% at about 5 Gy. Smaller dose enhancements (under the same measurement conditions) were observed for megavoltage x-ray beams (up to 10%). Dose enhancement caused by charged particles indicated minimal values for 6 MeV electrons (approximately 5%) whilst less than that is obtained with protons of 150 MeV. The proton results validate the latest simulation results based on Monte Carlo calculations but the dose enhancement is significantly less than that reported in cell and animal model systems, (about 20%). We attribute this difference to the fact that alanine only measures the levels of free radicals generated by the inclusion of nanoparticles and not the redox type radicals (such as reactive oxygen species) generated from aqueous media in cells.Dose enhancement caused by 5 nm gold-nanoparticles with radiotherapy type proton beams has been found to be less than 5% as determined when using alanine/wax as both a phantom and dosimeter. This agrees well with the latest Monte Carlo simulation results for similar sized gold-nanoparticles. Furthermore, our results for both low and high energy x-rays are validated against published data for in vitro studies.